Article
The Lancet Infectious Diseases  (2025)

Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trial.

Moos, Verena; Kruger, J; Allers, Kristina; Moter, Annette; Kikhney, Judith; Kühl, Anja A; Loddenkemper, Christoph; Stroux, A.; Schinnerling, Katina; Schneider, Thomas